chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm where injected within an hour or so, became more sore over the next day followed by chills, body aches, headache and slight fever starting the morning after vaccination; Sore arm where injected within an hour or so, became more sore over the next day followed by chills, body aches, headache and slight fever starting the morning after vaccination; Sore arm where injected within an hour or so, became more sore over the next day followed by chills, body aches, headache and slight fever starting the morning after vaccination; Sore arm where injected within an hour or so, became more sore over the next day followed by chills, body aches, headache and slight fever starting the morning after vaccination; Sore arm where injected within an hour or so, became more sore over the next day followed by chills, body aches, headache and slight fever starting the morning after vaccination; This is a spontaneous report received from a contactable consumer (patient). A 27-year-old female patient (not pregnant) received first dose of BNT162B2 (COVID 19, Pfizer, Solution for injection, Lot number: EL3247), intramuscular on left arm on 27Jan2021, 10:00 AM at single dose for COVID-19 immunization. Relevant medical history included minor allergies to avocados, almonds, and kiwis. Concomitant medications in two weeks included birth control and Vitamin D NOS (vitamin D supplement). No other vaccine was received by the patient within four weeks. On 27Jan2021 at 11:30 AM, the patient experienced sore arm where injected within an hour or so, became more sore over the next day (28Jan2021) followed by chills, body aches, headache and slight fever starting the morning after vaccination on 28Jan2021. No treatment was received by the patient. The patient was not tested COVID prior and post vaccination. On 03Feb2021, the patient stated that on 27Jan2021, the patient received the vaccination and first had the soreness. The patient reported on 29Jan2021 when patient had recovered from symptoms. The outcome of the events was recovered on 29Jan2021.  No follow-up attempts are possible. No further information is expected.
Patient awoke with injection site severly swollen, red, hot, and firm to the touch.  Also made her arm hurt.
12 hours following injection, nausea leading to vomiting and heat flush.  Fine immediately following vomiting.
Patient was administered the pediatric pfizer vaccine that had not been diluted.  No adverse events have been reported at this time.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age/gender. The patients' concurrent or historical conditions were not provided. Concomitant therapies were not reported. On an unknown date the patients were vaccinated with improperly stored (incorrect product storage) M-M-R II (dose, frequency and route were not provided). No symptoms were reported with regard to the medication error. This is one of several reports received from the same reporter. Additional information has been requested.
Supple, raised warm red lesion 6cm on left arm at injection site.  Treated with cool compress, ibuprofen, BENADRYL, and AUGMENTIN cs 600 x10 days.
This spontaneous report as received from a registered nurse refers to a 12 month old patient. On 28-JUN-2013 the patient was inadvertently vaccinated with a dose of RECOMBIVAX HB in error who was scheduled to receive VAQTA. No adverse event was reported. It was unknown if the patient sought medical attention. At the time of report, the status of patient was unknown. Additional information has been requested.
I have had a consistent headache since the day I received the first shot.  The headaches have continued even after the second shot.
A non-serious report was received from a physician of FLUMIST INADVERTENTLY ADMINISTERED involving a 63-year-old male. The patient's medical history includes chronic heart disease. No concomitant medications were reported for this patient. The patient received FluMist on 20 Nov 2007. On 20 Nov 2007, the patient was inadvertently administered FluMist vaccine. FluMist vaccine is approved for patients between 5 and 49 years of age. The reporter indicated that no adverse event occurred as a result of FluMist vaccination. No adverse event was reported. Rechallenge is not applicable. The reporter did not provide a causality assessment. The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
Fever onset approx 430PM of 104 degrees APAP given 840 fever fluctuated through out noc; In middlet of noc pt awoke & had a sz; Parent gave cool baths; In AM pt seen by MD;
Itching, redness and swelling on right arm below elbow 3rd day after vaccination. He tried OTC BENADRYL for itching but it did not help. At 5th day, he experienced the same symptoms on left arm. He has seen the doctor and get medication (prednisone-oral). As per patient information, he become symptoms free in 48 hours after starting therapy. He has done couple of test at doctor office. All results are normal per patient information over the phone.
muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FISH OIL, LIOTHYRONINE, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MUSCLE TWITCHING (muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip). At the time of the report, MUSCLE TWITCHING (muscle twitching right calf and left eyebrow / constant muscle twitching throughout body including stomach, back, lip) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Benadryl 25mg.   Reporter did not allow further contact
Patient was accidently given the "old" covid booster instead of the new bivalent booster,
During 15 minute observation period, complained of chest tightness, trouble breathing, headache, lightheadedness.  B/P was elevated at 183/109, HR90, O2 96% lungs clear, cardiac RRR epi not given due to allergy.  Oxygen placed at 2 liters per minute, given 125mg of solumedrol IM .  1143 B/P 194/102, hear rate 92.  911 initiated.  12 lead EKG done and read by Medical Director.  0.4mg NTG SL given, ASA 324mg chewed.  At 1149 EMS here .  O2 sat was 91%.  Last B\p was 194/102.  Transported to the ER by EMTs
Pt claims having a blistering rash on hands and thinks it was caused by her booster shot. Vaccine was given 12/02/2021 and reported 01/18/2022 that she started having  blisters showing up 2 weeks ago and is certain it is from the vaccine. I tried reaching back out to her and there is no answer!
headache; nausea; muscle pain; tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), administration date 09Apr2021 (Batch/Lot number: unknown) at the age of 75 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEXAPRO. The following information was reported: FATIGUE (non-serious) with onset 09Apr2021, outcome "not recovered", described as "tiredness"; HEADACHE (non-serious), outcome "unknown", described as "headache"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain".  Additional Information: Patient has been experiencing tiredness, headache, nausea, muscle pain questioning that how long will the symptoms last, Husband died and she is just living alone, she wants an assurance that she is ok and nothing to worry about her symptoms. Physician's Assistant told patient to rest and drink fluids. Patient reclarified states she takes Lexapro, and her husband died suddenly and she moved to (Name withheld) and her grandkids are there.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pregnant with estimated due date of 8/8/21. First pregnancy no complications.  Symptoms. Mild chills, aches, and slight nausea. No fever
Vaccine given 5/8/09. Fever to 101.5. Syncopal episode, pain and swelling of injected arm. Symptoms began day after injection. Still present but resolving 5/13/09.
Sore and redness to the left of the injection. Told patient to take ibuprofen and benadryl. Use cold compress.
Presented w/ gen. weakness, decreased appetite, n/v, cough. Prior Covid infection X 3 weeks ago. Also rpts lft foot wound drainage. Treated covid w/ vit C, zinc, singular, antitussies
No additional AE or PQC reported; Caller explained a 59 year old patient was administered GARDASIL 9 in error; patient was administered GARDASIL 9 in error; This spontaneous report was received from a registered nurse and refers to a 59-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 16-AUG-2022, the patient was vaccinated in an error with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)pre-filled syringe injection, lot #U037063 was confirmed to be valid, expiration date: 21-OCT-2023, administered for prophylaxis (dose, anatomical location and route of administration were not provided)(Inappropriate age at vaccine administration and wrong product administered). No additional adverse event was reported.
Sore arm to the touch; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN5318), via an unspecified route of administration, in the left arm on 04Feb2021 at 01:30 PM (at the age of 72-years-old) as single dose for COVID-19 immunisation. Medical history included bundle branch block. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient had no known allergies. Concomitant medications included metoprolol (METOPROLOL); diltiazem (DILTIAZEM); attracting; escitalopram oxalate (LEXAPRO) and tadalafil (TADALAFIL). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced sore arm to the touch on 05Feb2021 at 06:30 AM. No treatment was received for the event. Outcome of the event was recovered on an unspecified date.   No follow-up attempts are possible. No further information expected.
Flu symptoms; Lightheadedness; Loss of balance, Losing balance when he is walking; Inappropriate shedule of vaccine administartion; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms), DIZZINESS (Lightheadedness), BALANCE DISORDER (Loss of balance, Losing balance when he is walking) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate shedule of vaccine administartion) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A, 029L20A and 026L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL), AMIODARONE, APIXABAN (ELIQUIS), ATORVASTATIN, DUPILUMAB (DUPIXENT), ADALIMUMAB (HUMIRA), LISINOPRIL, OMEPRAZOLE and VITAMINS NOS for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu symptoms), DIZZINESS (Lightheadedness), BALANCE DISORDER (Loss of balance, Losing balance when he is walking) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate shedule of vaccine administartion). At the time of the report, INFLUENZA (Flu symptoms), DIZZINESS (Lightheadedness) and BALANCE DISORDER (Loss of balance, Losing balance when he is walking) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate shedule of vaccine administartion) had resolved.            No treatment information was provided.
Site is very sore, red, warm to touch, and swollen to size of baseball.  Also itches. Headache and fever of 100.  Hurts to move or lift left arm.
On 11/16/2005 Starting with pruritus on back. On 11/17/2005 developed a patchy area on back, pruritic it raised with blisters forming. Saw MD on 11/25/05 due to additional raised patches on mid back and right ribs and pain. Placed on RX acyclovir 5 QD for 7 days. Out of work 11/28/08 to 12/02/05. Saw MD again 11/29/05 for increased pain, placed on Gabapentin. As of 12/08/2005 done with acyclovir and off Gabapentin and returned to work 12/05/05. Has pain on and off now. Continues with pruritus and rash resolving, blisters are resolved.
When pt presented for booster 11/29/21, pt states she felt her throat start to close approx 15 mins after 2nd moderna shot but thinks it was a panic attack. Symptoms resolved after 5 mins.  Pt refused vaccination until getting clearance from PCP.  Pt returned 11/30 and recieved booster dose.  No adverse reaction noted as of 12/21/21. Review of medical records indicates the following symptoms at the time of vaccination on 4/19/21: Itchiness in throat, mild difficulty breathing. Pt given 2L via NC. Objective findings: Pt had no visible swelling or rashes. Her throat was mildly erythmatous but NOT swollen.  Breathing normal, pulse normalized. Normal breath sounds, no rales or wheezes.   Probably anxiety induced reaction,  Resolved quickly with no further intervention.
can't walk on one of my legs; swollen; muscle pain; joint pain; having pain her legs; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 71-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry date were not reported) via an unspecified route of administration on 02Mar2021 as dose 2, single (age at vaccination: 71-year-old) for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiry date were not reported) via an unspecified route of administration on an unspecified day as dose 1, single for COVID-19 immunisation. On an unspecified date, the patient experienced can't walk on one of her legs, swollen, muscle pain, joint pain, having pain her legs. The patient had taken Tylenol and Advil, but they aren't helping. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
19 mon. male vaccinated /w MMRII vaccine. 17Mar90, developed a maculopapular rash of both arms, legs & cheek /w high fever. Rash became purpuric 2Apr90.  Rash remitted spontaneously total duration 15-17 days. No further info. provided
post inflammatory nodules; swelling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the patient. Other Case identifier(s): GL-030122-5224 (RA).  A female patient received bnt162b2 (BNT162B2), administration date 02Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; hyaluronic acid (RESTYLANE), from 13Sep2021 (Batch/Lot number: unknown) to 01Feb2022. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFECTED NEOPLASM (non-serious) with onset 18Feb2022, outcome "unknown", described as "post inflammatory nodules"; SWELLING (non-serious) with onset 18Feb2022, outcome "unknown", described as "swelling". The action taken for hyaluronic acid was unknown. Therapeutic measures were taken as a result of infected neoplasm, swelling. Additional information: Patient /HCP reported post inflammatory nodules and swelling after Restylane Lyft, Restylane Defyne, Restylane, Refyne and Restylane Contour injections. Treatments given from 13Sep2021-01Feb2022. Adverse event started was reported as 18Feb2022. Pfizer Covid vaccine dates were reported as dose 1 on 02Feb2021 and dose 2 on 23Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pfizer / BioNTech dose 3 / Treatment of COVID-19; Pfizer / BioNTech dose 3 / Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 21-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Oct2021 as dose 3 (booster), single (Lot number: 320308D) at the age of 21 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "autism" (unspecified if ongoing); "adhd" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "asthma" (unspecified if ongoing); "vocal cord dysfunction" (unspecified if ongoing); "known allergies: Almonds" (unspecified if ongoing), notes: known allergies: Almonds; "Allergy" (unspecified if ongoing); "Birth control pill" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC ALLERGY taken for hypersensitivity, start date: 22Aug2014. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "not recovered", COVID-19 (medically significant), outcome "recovered" and all described as "Pfizer / BioNTech dose 3 / Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results; Negative; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: The patient received other medication in 2weeks. The patient received COVID 19 Treatment, (Paxlovid) from 03Jun2022 to 07Jun2022 for treatment of COVID-19. Adverse event I am experiencing rebound symptoms. I am day 12 of my covid illness and was symptom free since day 6. I tested negative day 10, but test positive day 12 after having new onset of symptoms (runny nose, sneezing, congestion, headache, fatigue, SOB). I likely exposed 4 different people today.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received; Sender's Comments: As there is limited information in the case provided, the causal association between the event and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Pain and swelling of injection site with in 2 hours, fatigue within 2 hours. headache, chills, body ache, mild fever (100.5) wihin 12 hours, OTC med helped with headache and chills. Milder symptoms of the same persisted for 24 hours, mild pain at injection site for 48 hours
This spontaneous report as received from a pharmacist refers to approximately 60 year old male patient. the patient's medical history and concurrent conditions were not known. On an unknown date in January 2015, the patient was vaccinated with PNEUMOVAX 23 (lot # K006681). On an unknown date in January 2015 (reported as "at the same time" of vaccination), the patient had splenectomy. The reporter did not know if PNEUMOVAX 23 was given before or after the splenectomy and did not know why the patient had a splenectomy. The patient was hospitalized at an unspecified facility for the splenectomy for an unspecified amount of time. The outcome of the event splenectomy was unknown. The reporter did not provide the causality between the event and the suspect therapy. The event splenectomy was considered as serious due to hospitalization. Upon internal review the event splenectomy was considered as serious (medically significant). Additional information is not expected as the reporter does not want to be contacted.
Pulmonary embolism; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY EMBOLISM (Pulmonary embolism) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Neurofibromatosis (50 pound tumor on his left leg due to the condition.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PULMONARY EMBOLISM (Pulmonary embolism) (seriousness criteria hospitalization and medically significant). At the time of the report, PULMONARY EMBOLISM (Pulmonary embolism) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient got first dose of Moderna vaccine and within 16-18 days went to emergency room and had pulmonary embolism. Was in the hospital and given heparin and eventually sent home.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Pt recvd Hep B vax on 2APR92 & worsening of pain, pain in hip, shoulder & rt thumb, arthralgia;
On 6/11/21, day 2 after vaccine, I had body aches and lymph nodes were very sore and swollen. I had a lot of doctor appointments following the dose. I followed up with my primary care doctor. I have diabetes and my sugar stayed high since COVID-19 in February of 2021. I could feel my lymph node in my neck if I turned my head. Doctors could not figure out why. My left shoulder was swollen. It resolved sometime in the fall, September or October of 2021.